Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individuals

The rapid development of mRNA-based vaccines against the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) led to the design of accelerated vaccination schedules that have been extremely effective in naive individuals. While a two-dose immunization regimen with the BNT162b2 vaccine has be...

Full description

Saved in:
Bibliographic Details
Published inCell reports (Cambridge) Vol. 36; no. 8; p. 109570
Main Authors Lozano-Ojalvo, Daniel, Camara, Carmen, Lopez-Granados, Eduardo, Nozal, Pilar, del Pino-Molina, Lucía, Bravo-Gallego, Luz Yadira, Paz-Artal, Estela, Pion, Marjorie, Correa-Rocha, Rafael, Ortiz, Alberto, Lopez-Hoyos, Marcos, Iribarren, Marta Erro, Portoles, Jose, Rojo-Portoles, Maria Pilar, Ojeda, Gloria, Cervera, Isabel, Gonzalez-Perez, Maria, Bodega-Mayor, Irene, Montes-Casado, Maria, Portoles, Pilar, Perez-Olmeda, Mayte, Oteo, Jesus, Sanchez-Tarjuelo, Rodrigo, Pothula, Venu, Schwarz, Megan, Brahmachary, Manisha, Tan, Anthony Tanoto, Le Bert, Nina, Berin, Cecilia, Bertoletti, Antonio, Guccione, Ernesto, Ochando, Jordi
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 24.08.2021
The Authors
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…